Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Healthcare stocks surge after Biden's surprise Super Tuesday performance

The healthcare industry has long viewed the former vice president as a friendly candidate

Graig Graziosi
Wednesday 04 March 2020 19:15 EST
Comments
Super Tuesday round up: Joe Biden's huge comeback puts him head-to-head with Sanders

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Healthcare stocks surged on Wednesday following a strong showing by former vice president Joe Biden on Super Tuesday.

The Dow Jones Industrial Average traded 577 points higher and the S&P 500 jumped 1.8 per cent. The Nasdqaq Composite climbed 1.7 per cent.

CNBC reported that the results of Super Tuesday boosted health care stocks, resulting in The Health Care Select Sector trading more than three per cent higher. UnitedHealth jumped 10 per cent and Centene rose 12.9 per cent.

Unlike the more progressive healthcare plans championed by Senators Bernie Sanders and Elizabeth Warren, Mr Biden’s plan would reinvest in the Affordable Care Act – despite the act being partially dismantled by the Trump administration and a federal judge ruling it unconstitutional – and cap inflation on prescription drug prices.

The relief the health insurance industry seems to feel at the prospect of a Joe Biden presidency is not necessarily congruent to the feelings of the American people, however.

According to exit polls from the Super Tuesday elections, Democratic voters in the 12 states conducting exit polling all supported a “government plan for all” instead of “private insurance” when asked about healthcare.

It was no secret that investors were becoming nervous at the prospect of an Oval Office occupied by Ms Warren or Mr Sanders.

Ed Yardeni, president and chief investment strategist at Yardeni Research issued a memo expressing relief at any sign that the progressive candidates can be stopped.

“Investors fear Bernie because he wants to cut off the head of capitalism by raising taxes significantly on the rich and using the funds to provide free everything to everyone else,” Mr Yardeni said.

The “free everything” Mr Yardeni laments are programs meant to provide healthcare to all Americans free at point of service and to provide higher education at no cost.

Vox reported that Mr Biden has long been the “white knight” of the health insurance industry, as he was one of the only Democrats to never come out in support of Medicare for All.

A “top trade association” president told the news website why they liked Mr Biden.

“The industry would just like to see a candidate who would be responsible and pragmatic,” they said. “From the industry standpoint, it’s like, what was all the energy about 2010? Biden would be more sympathetic toward that.”

The healthcare industry took in record profits last year. In quarter 2 of 2019, 12 of the 16 most profitable companies were pharmaceutical companies.

According to a Kaiser Family Foundation poll, drug spending per person in the US increased from $90 to $1,025 between 1960 and 2017. More than a quarter of adults responding to the poll said they have a “somewhat” or “very” difficult time affording their treatments.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in